Redux Bio is focused on advancing animal health through innovative product development aimed at managing infectious diseases. The company leverages RNA interference (RNAi) technology to create novel solutions that address unmet needs in the market. This approach allows Redux Bio to develop preventative disease management tools that offer sustainable alternatives to traditional antibiotics, specifically targeting livestock and aquaculture sectors. By utilizing RNAi, the company aims to enhance the health and productivity of animals while reducing reliance on conventional antibiotic treatments.

The expertise of Redux Bio's team is a significant asset, as it comprises seasoned professionals with extensive backgrounds in animal health, aquaculture, and regulatory affairs. This collective knowledge supports the company's mission to bring bio-based solutions to market effectively. The team's experience spans various critical areas, including vaccine development, industrial biotechnology, and product scaling, which are essential for the successful commercialization of their innovative health products. Through this combination of cutting-edge technology and expert guidance, Redux Bio is positioned to make a meaningful impact in the field of preventative medicine for animal health.

United States

Redux Bio is an animal health product development company that creates, cultivates, and commercializes novel solutions to manage infectious disease.

Redux Bio

Company Details